Grand Pharmaceutical Group's low P/E ratio reflects its poor...
Grand Pharmaceutical Group's low P/E ratio reflects its poor earnings outlook. Investors foresee limited growth, hence the reduced stock price. The share price is unlikely to see a significant rise soon.
Grand Pharmaceutical Group Limited's (HKG:512) Business And Shares Still Trailing The Market
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment